BSE filing, NSE: OMKARPH. Summary written from the filing by ALFA Finder's alert engine.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹6.25
- Market cap
- ₹6.30 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 74.0×Sector 34.1×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Other Announcement
Omkar Pharmachem Ltd filed its quarterly shareholding pattern and provided an explanation regarding missing PAN details for certain public shareholders.
Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Board Meeting Outcome
Omkar Pharmachem Ltd has announced the outcome of its board meeting, including the schedule for its 31st Annual General Meeting and related party transactions approval.
Omkar Pharmachem Q1 FY27 Results: Net Profit ₹0 Cr
Omkar Pharmachem Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Omkar Pharmachem Board Meeting Date
Omkar Pharmachem will hold a board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other annual general meeting announcements
All →Quint Digital Annual General Meeting
Quint Digital Limited reported postal ballot results, with all resolutions approved by members on 31 October 2026. The scrutinizer's report and voting results are enclosed, and the resolution texts are not in the extract.
TeleCanor Global Annual General Meeting
TeleCanor Global held its 34th AGM on 31-Oct-2026 and the proceedings were filed with the exchange. Two ordinary resolutions were put to members, covering adoption of FY2026 accounts and re-appointment of a retiring director.
Sun Pharmaceutical Industries Annual General Meeting
Sun Pharma's postal ballot passed all seven special resolutions, including ESOP 2026 approval and borrowing and security limits. No monetary transaction is stated.
Bondada Engineering Annual General Meeting
Bondada Engineering Ltd has called an extraordinary general meeting on 21 November 2026. Shareholders will vote on related-party loans, security creation and borrowing limits.
Uflex Annual General Meeting
Uflex shareholders approved a special resolution to borrow up to ₹5,000 Crore under Section 180(1)(c) via postal ballot, with 99.92% in favour. The result was declared on 31 October 2026.
Stovec Industries Annual General Meeting
Stovec Industries' shareholders approved two non-executive director appointments by postal ballot. Both resolutions passed with about 98% of votes polled in favour.